JANE STREET GROUP, LLC - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 46 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2021. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q2 2022$10,000
-63.0%
20,208
+51.7%
0.00%–
Q1 2022$27,000
-90.2%
13,317
-79.9%
0.00%–
Q4 2021$276,000
-84.2%
66,198
-64.8%
0.00%–
Q3 2021$1,746,000
-58.8%
187,819
-20.3%
0.00%
-100.0%
Q2 2021$4,243,000–235,600–0.00%–
 Download
Other shareholders

There were no reported owners of BROOKLYN IMMUNOTHERAPEUTICS in Q2 2021.

NameSharesValueWeighting ↓
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders